Barrier-method contraceptives and pelvic inflammatory disease

Area of Science:

• Reproductive Health
• Epidemiology
• Infectious Disease Prevention

Background:

• Pelvic inflammatory disease (PID) is a serious condition with significant health consequences.
• Understanding contraceptive methods' role in PID prevention is crucial for public health.
• Previous research has suggested a potential protective effect of certain contraceptives against PID.

Purpose of the Study:

• To evaluate the protective effect of barrier-method contraception against pelvic inflammatory disease (PID).
• To compare PID risk among users of barrier methods versus other contraceptive methods or no method.

Main Methods:

• Analysis of data from the Women's Health Study, a large multicenter case-control study.
• Comparison of contraceptive methods used by 645 women hospitalized for PID with 2,509 control subjects.
• Statistical analysis to determine the relative risk of PID hospitalization associated with barrier method use.

Main Results:

• Women currently using barrier methods had a reduced risk of hospitalization for PID (relative risk = 0.6).
• This protective effect was observed when compared to women using all other methods and those using no contraception.
• A protective effect was noted for both chemical and mechanical barrier methods, though not statistically significant for chemical methods.

Conclusions:

• Barrier methods of contraception demonstrate a protective effect against pelvic inflammatory disease (PID).
• Prevention of PID and its sequelae is a significant non-contraceptive benefit of barrier methods.
• These findings support the recommendation of barrier methods for women seeking to reduce PID risk.